跳至主要内容
临床试验/CTRI/2022/03/041022
CTRI/2022/03/041022已完成不适用

A clinical study to assess the effectiveness of individualized homoeopathic medicines in the treatment of chronic sinusitis

Bharathinesan M1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年3月15日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Chronic sinusitis assessment score

研究概览

简要总结

This study is an open label, prospective, uncontrolled clinical trail to assess the effecetiveness of individualized homoeopathic medicines in the treatment of chronic sinusitis.

Hypothesis depends upon significant changes in the symptoms of chronic sinusitis after six months of intervention with homoeopathic medicines, no significant changes in the symptoms null hypothesis applied, if significant changes in the symptoms alternative hypothesis is applied.

Objectives are to assess the treatment outcome by using chronic sinusitis assessment score as primary treatment outcome and using numeric rating scales as secondary outcome. To shortlist the frequently indiacated medicines in the treatment of chronic sinusitis.

Study duration is one year. 30 patients are included in the study, patients are followed every month upto six month, the outcomes are measured every 4 weeks upto 24 weeks.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients having chronic sinusitis more then 12 weeks.
  • Patients who have not taken any treatment since last two weeks for chronic sinusitis.
  • Patients willing to take homoeopathic treatment.

排除标准

  • Patients suffering from uncontrlled systemic diseases like cancer, vital organ failures, uncontrolled infections.
  • Immunocompromised patients, psychiatrically unstable patietnts, pregenent and lactating females.

结局指标

主要结局

Chronic sinusitis assessment score

时间窗: Every 4 weeks upto 24 weeks

次要结局

  • Numeric rating scale(Every 4 weeks upto 24 weeks)

研究者

发起方
Bharathinesan M
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验